Ryan Vandrey
Johns Hopkins University
H-index: 49
North America-United States
Top articles of Ryan Vandrey
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products | Journal of Analytical Toxicology | C Austin Zamarripa Hayleigh E Tilton Spencer Lin Edward J Cone Ruth E Winecker | 2024/3/1 |
The psychedelic effects of cannabis: A review of the literature | David Wolinsky Frederick Streeter Barrett Ryan Vandrey | 2024/1 | |
Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder | Journal of Substance Use and Addiction Treatment | Dustin C Lee Nicolas J Schlienz Evan S Herrmann Erin L Martin Jeannie Leoutsakos | 2024/1/1 |
‘I crave not to feel uncomfortable’–investigating craving for opioids and cannabis among individuals with chronic pain | Drugs: Education, Prevention and Policy | Johannes Thrul Courtney D Nordeck Janardan Devkota Chung Jung Mun Kelly E Dunn | 2024/4/2 |
Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis | Drug and alcohol dependence | Tory R Spindle C Austin Zamarripa Ethan Russo Lauren Pollak George Bigelow | 2024/4/1 |
Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC) | Neuropsychopharmacology | Lindsay A Lo April L Christiansen Justin C Strickland Carly A Pistawka Lauren Eadie | 2024/3/25 |
Likelihood of positive urine screens of THC-COOH after daily use of full-spectrum hemp extracts varies as a function of screening criterion used | Therapeutic drug monitoring | Morgan L Ferretti Ryan Vandrey Jessica G Irons Heather Jackson Mallory J Loflin | 2023/2/1 |
Pilot trial of Dronabinol adjunctive treatment of agitation in Alzheimer’s disease (THC‐AD) | Alzheimer's & Dementia | Paul B Rosenberg John D Outen Halima Amjad Haroon Burhanullah Ryan Vandrey | 2023/6 |
An overview of current pharmacologic interventions for management of cannabis withdrawal syndrome and the evidence for their use | David Wolinsky Ryan Vandrey | 2023/1/1 | |
Immediate Switching to Reduced Nicotine Cigarettes in a US-Based Sample: The Impact on Cannabis Use and Related Variables at 20 Weeks | Nicotine and Tobacco Research | Ellen Meier Nathan Rubin Sarah S Dermody Katelyn M Tessier Stephen S Hecht | 2023/5/1 |
Parameters of EMA Compliance and Self-Reported Reactivity in a Longitudinal Study of Young Adult Cannabis and Tobacco Co-Users | Cannabis | Taylor Niznik Sarah J Ehlke Robin Mermelstein Ryan Vandrey Donald Hedeker | 2023 |
A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products | Drug and alcohol dependence | Ashley N Dowd C Austin Zamarripa Dennis J Sholler Justin C Strickland Elia Goffi | 2023/4/1 |
Clinical trial design challenges and opportunities for emerging treatments for opioid use disorder: A review | Brian D Kiluk Bethea A Kleykamp Sandra D Comer Roland R Griffiths Andrew S Huhn | 2023/1/1 | |
A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol. | Experimental and clinical psychopharmacology | Cecilia L Bergeria Justin C Strickland Tory R Spindle Maja Kalaba Prem Umang Satyavolu | 2023/4 |
Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain | Neuropsychopharmacology | Claudia M Campbell Chung Jung Mun Katrina R Hamilton Cecilia L Bergeria Andrew S Huhn | 2023/5/18 |
Assessment of orally administered Δ9-tetrahydrocannabinol when coadministered with cannabidiol on Δ9-tetrahydrocannabinol pharmacokinetics and pharmacodynamics in healthy … | JAMA Network Open | C Austin Zamarripa Tory R Spindle Renuka Surujunarain Elise M Weerts Sumit Bansal | 2023/2/1 |
Evaluation of Cytochrome P450‐Mediated Cannabinoid‐Drug Interactions in Healthy Adult Participants | Clinical Pharmacology & Therapeutics | Sumit Bansal C Austin Zamarripa Tory R Spindle Elise M Weerts Kenneth E Thummel | 2023/9 |
Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes | Preventive medicine | Elias M Klemperer Xianghua Luo Joni Jensen Mustafa Al'Absi Paul M Cinciripini | 2022/12/1 |
Behavioral economic interactions between cannabis and alcohol purchasing: Associations with disordered use. | Experimental and clinical psychopharmacology | Sean B Dolan Tory R Spindle Ryan Vandrey Matthew W Johnson | 2022/4 |
The iCannToolkit: a tool to embrace measurement of medicinal and non‐medicinal cannabis use across licit, illicit and cross‐cultural settings | Addiction (Abingdon, England) | Valentina Lorenzetti Chandni Hindocha Kat Petrilli Paul Griffiths Jamie Brown | 2022/6 |
